SEC Form 4 · accession 0000899243-19-005210
Lantheus Holdings, Inc. · LNTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cesare Orlandi
Officer — Chief Medical Officer
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001521036
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | A | 13,426 | $0.00 | A | 87,115 | D | |
| Common StockF2 | Feb 27, 2019 | S | 3,111 | $23.102 | D | 84,004 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.56 to $23.62, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.